Results
1 -
10 of
33
(Click
here to explore results)
- Pharmaceutical Salts and Co-crystals, Chapter 13 Limits of the Co-crystal Concept and Beyond. Gerard Coquerel
, 2012
, Pages 300-317
- Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Chapter 6 New Drug Design and Therapeutic Development for Weight Reduction: Preclinical Studies and Clinical Trials. Steven P. Vickers, Helen C. Jackson, Sharon C. Cheetham
, 2015
, Pages 90-116
- Drug Repurposing, Chapter 15 Future Perspectives in Drug Repurposing. David Cavalla
, 2022
, Pages 301-319
- The Handbook of Medicinal Chemistry: Principles and Practice, CHAPTER 15 Discovery Toxicology In Lead Optimisation. Simone Braggio, Mauro Corsi, Aldo Feriani, Stefano Fontana, Luciana Marocchio, Caterina Virginio
, 2015
, Pages 364-412
- Forensic Chemistry of Substance Misuse: A Guide to Drug Control (2), CHAPTER 8 Structure-specific Generic Legislation
, 2022
, Pages 79-126
- Foreign Compound Metabolism in Mammals: Volume 5, Effect of drugs on the central nervous system. D. E. Hathway, B. E. Leonard
, 1979
, Volume 5
, Pages 244-319
- Drug Discovery for Psychiatric Disorders, CHAPTER 18 Medicinal Chemistry Challenges in CNS Drug Discovery. Matilda Bingham, Zoran Rankovic
, 2012
, Pages 465-509
- Drug Discovery for Schizophrenia, CHAPTER 8 GSK3 Networks in Schizophrenia. Jivan Khlghatyan, Gohar Fakhfouri, Jean-Martin Beaulieu
, 2015
, Pages 173-201
- Biomedical Imaging: The Chemistry of Labels, Probes and Contrast Agents, Chapter 3 Recent Developments in PET and SPECT Radioligands for CNS Imaging. David Alagille, Ronald M. Baldwin, Gilles D. Tamagnan
, 2012
, Pages 49-143
- Foreign Compound Metabolism in Mammals: Volume 2, Compound index. D. E. Hathway
, 1972
, Volume 2
, Pages 475-492